CHURCHILL MANAGEMENT Corp trimmed its holdings in Agilent Technologies Inc (NYSE:A) by 2.0% during the fourth quarter, HoldingsChannel reports. The firm owned 80,126 shares of the medical research company’s stock after selling 1,619 shares during the period. CHURCHILL MANAGEMENT Corp’s holdings in Agilent Technologies were worth $5,366,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Sumitomo Mitsui Trust Holdings Inc. raised its position in shares of Agilent Technologies by 9.9% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 998,225 shares of the medical research company’s stock valued at $64,086,000 after purchasing an additional 90,317 shares in the last quarter. Timber Hill LLC acquired a new position in shares of Agilent Technologies in the 3rd quarter valued at approximately $1,672,000. PNC Financial Services Group Inc. raised its position in shares of Agilent Technologies by 720.6% in the 2nd quarter. PNC Financial Services Group Inc. now owns 1,131,276 shares of the medical research company’s stock valued at $67,097,000 after purchasing an additional 993,414 shares in the last quarter. Colony Group LLC acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at approximately $260,000. Finally, Fisher Asset Management LLC acquired a new position in shares of Agilent Technologies in the 3rd quarter valued at approximately $609,000.
A has been the topic of a number of recent analyst reports. Goldman Sachs Group reaffirmed a “neutral” rating and issued a $68.00 target price on shares of Agilent Technologies in a research report on Tuesday, September 26th. Cowen reaffirmed a “hold” rating and issued a $65.00 target price on shares of Agilent Technologies in a research report on Thursday, September 28th. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price target for the company in a report on Tuesday, October 10th. Robert W. Baird reiterated a “buy” rating and issued a $70.00 price target on shares of Agilent Technologies in a report on Friday, October 20th. Finally, Morgan Stanley reiterated an “overweight” rating on shares of Agilent Technologies in a report on Tuesday, November 14th. Six research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $68.98.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a return on equity of 16.95% and a net margin of 15.30%. The business had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the previous year, the business earned $0.59 EPS. The business’s quarterly revenue was up 7.0% on a year-over-year basis. sell-side analysts predict that Agilent Technologies Inc will post 2.58 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Investors of record on Tuesday, January 2nd will be paid a dividend of $0.149 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 dividend on an annualized basis and a yield of 0.84%. The ex-dividend date is Friday, December 29th. Agilent Technologies’s dividend payout ratio is presently 28.71%.
In related news, CEO Michael R. Mcmullen sold 22,481 shares of the company’s stock in a transaction on Monday, November 20th. The stock was sold at an average price of $70.00, for a total transaction of $1,573,670.00. Following the completion of the transaction, the chief executive officer now directly owns 327,882 shares in the company, valued at approximately $22,951,740. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Jacob Thaysen sold 22,583 shares of the company’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $70.41, for a total value of $1,590,069.03. Following the transaction, the senior vice president now owns 63,042 shares of the company’s stock, valued at $4,438,787.22. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 176,291 shares of company stock valued at $12,245,920.
WARNING: This piece was first published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this piece can be accessed at https://www.com-unik.info/2018/01/12/agilent-technologies-inc-a-holdings-lessened-by-churchill-management-corp.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
What are top analysts saying about Agilent Technologies? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Agilent Technologies and related companies.